DNA sequences comprising dystrophin minigenes and methods of use thereof |
| The present invention provides dystrophin minigenes that are significantly reduced in size without ... |
|
Pharmaceutical composition and method for hypermetabolic weight loss |
| The present invention relates to a device, pharmaceutical composition and method for metabolizing ... |
|
Method for manufacturing glycoproteins having human-type glycosylation |
| What is claimed is: 1. A method of manufacturing a glycoprotein having a sugar chain, comprising a ... |
|
Dimeric fluorescent energy transfer dyes comprising asymmetric cyanine azole-indolenine chromophores |
| What is claimed is: 1. A compound of the formula: ##STR2## wherein: a is from 0 to 6,: b is from 0 ... |
|
Nucleic acid analogue induced transcription of double stranded DNA |
| We claim: 1. A method of transcribing RNA, using a double-stranded DNA as a template, comprising: (... |
|
Peptide nucleic acid combinatorial libraries |
| OF THE INVENTION The synthesis of peptide nucleic acids (also known as PNA) via preformed monomers ... |
|
Nucleic acid-containing polymerizable complex |
| OF THE INVENTION The present invention is based on the development of a polymerizable complex ... |
|
Chiral peptide nucleic acids and methods for preparing same |
| OF THE INVENTION Specific sequence recognition of DNA or RNA is of increasing importance for the ... |
|
Capillary electrophoretic detection of nucleic acids |
| OF THE PREFERRED EMBODIMENTS This invention provides novel methods for the detection and isolation ... |
|
|
Nucleic acid diagnostics based on mass spectrometry or mass separation and base specific cleavage
| Details |
Inventors: Foote, Simon; Elso, Colleen; Simpson, Richard; Reid, Gavin;
Assignee: The Walter and Eliza Hall Institute of Medical Research (Victoria, AU)
Primary Examiner: Fredman; Jeffrey
Assistant Examiner: Chakrabarti; Arun
Attorney, Agent or Firm: Scully, Scott, Murphy & Presser
A method of detecting a mutation or a difference of one or more nucleotides between a nucleic acid molecule to be tested and a reference nucleic acid molecule, said method comprising subjecting the test nucleic acid molecule to base specific cleavage to generate oligonucleotide fragments, separating the resulting oligonucleotide fragments based on mass by MALDI-ATOF MS and/or other equivalent procedure to produce a fingerprint of then oligonucleotide fragments comprising one or more peaks wherein a peak represents the mass of each fragment and identifying an altered peak relative to a reference nucleic acid molecule subjected to the same procedure wherein the presence of an altered peak is indicative of a difference of one or more nucleotides in said tested nucleic acid molecule. |
|
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention is predicated in part on a base specific cleavage reaction to generate a set of small oligonucleotides bounded by the base cleaved. The nucleic acid molecule may be completely or only partially cleaved or digested. These fragments are then separated based on mass by MALDI-TOF MS. This generates a fingerprint of the nucleic acid fragment comprising a series of peaks where each peak represents the mass of each small cleavage product. As a result of the sensitivity of mass determination, each oligonucleotide of given length but different nucleotide composition produces a different mass. The mass of each peak, therefore, corresponds to the nucleotide composition of the fragment as well as to its length. Consequently, any nucleotide substitution results in either a shifted peak due to the mass difference in the new cleavage fragment or, if the mutation changes the targeted base, a cleavage product containing a different number of bases. Accordingly, one aspect of the present invention contemplates a method of detecting a difference of one or more nucleotides between a nucleic acid molecule to be tested and a reference nucleic acid molecule, said method comprising subjecting the test nucleic acid molecule to base specific cleavage to generate oligonucleotide fragments, separating the resulting oligonucleotide fragments based on mass by MALDI-TOF MS and/or other equivalent procedure to produce a fingerprint of the oligonucleotide fragments comprising one or more peaks wherein a peak represents the mass of each fragment and identifying an altered peak relative to a reference nucleic acid molecule subjected to the same procedure wherein the presence of an altered peak is indicative of a difference of one or more nucleotides in said tested nucleic acid molecule. Conveniently, screening is carried out by comparing the cleavage product masses of the reference or wild-type nucleic acid to those of the test sample. Mass changes corresponding to base changes are readily observed
|
| Related patents |
|
|
Polymer microparticles for drug delivery
OF THE INVENTION The term microparticle is used herein to include nanoparticles. The microparticles preferably have a size in the range 10 nm to 200.mu.m. The water-...
|
|
|
Rapid release encapsulated bioactive agents for inducing or potentiating an immune response and methods of using thereof
The present invention provides bioactive agents encapsulated in a rapidly releasing polymeric composition capable of inducing or potentiating an immune response and ...
|
|
|
Disaccharide derivatives for treating hyperglycaemia
The invention claimed is: 1. A drug composition comprising an active ingredient and a carrier in which said active ingredient is an amide or alkyl ester of an oxidized ...
|
|
|
Gene expression profiles in liver cancer
1. A method of diagnosing hepatocellular carcinoma in a human patient, compnsing: (a) detecting the level of expression in a tissue sample of ten or more genes from T...
|
|
|
Endovascular cardiac venting catheter and method
The present invention is directed to an endovascular approach for preparing a patient's heart for cardiac procedures which does not require a grossly invasive ...
|
|
|
Bone morphogenic protein-5(BMP-5) and DNA encoding same
OF THE INVENTION Purified human BMP-5 proteins are produced by culturung a host cell transformed with the DNA sequence of Table III. The expressed BMP-5 proteins are ...
|
|
|
Adipocyte-specific protein homologs
Within one aspect of the invention is provided an isolated polypeptide comprising a sequence of amino acid residues that is at least 80% identical to SEQ ID NO:2, ...
|
|
|
LSR receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
The LSR receptor The invention relates to a purified LSR receptor (<<Lipolysis Stimulated Receptor>>), preferably hepatic, consisting of at least one .alpha....
|
|
|
Multi-functional chimeric hematopoietic receptor agonists
1. A hematopoietic protein comprising; an amino acid sequence of the formula: Met-1 R1-L1-R2, Met-2 Ala-1 P1-L1-R2, Ala-1 R1-L1-R2, R1-L1-R2, Met-1 R2-L1-R1, Met-2 Ala-1 ...
|
|
|
Composition and method for treatment and prevention of traumatic synovitis and damage to articular cartilage
OF THE INVENTION Additional objects, advantages and other novel features of the invention will be set forth in part in the description that follows and in part will ...
|
|
|